Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models.
作者信息
Lam Sze-Kwan, Mutsaers Steven Eugene
机构信息
Division of Respiratory Medicine, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia.
出版信息
Front Pharmacol. 2022 Sep 6;13:1015959. doi: 10.3389/fphar.2022.1015959. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models.社论：临床前模型中治疗恶性胸膜间皮瘤的新型药物及联合用药
Front Pharmacol. 2022 Sep 6;13:1015959. doi: 10.3389/fphar.2022.1015959. eCollection 2022.
2
Novel therapies for malignant pleural mesothelioma.恶性胸膜间皮瘤的新型治疗方法。
Lancet Oncol. 2018 Mar;19(3):e161-e172. doi: 10.1016/S1470-2045(18)30100-1.
3
Clinical course of human epithelial-type malignant pleural mesothelioma replicated in an orthotopic-transplant nude mouse model.人上皮型恶性胸膜间皮瘤的临床病程在原位移植裸鼠模型中的复制情况。
Anticancer Res. 1996 Mar-Apr;16(2):633-9.
4
The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.选择性表皮生长因子受体酪氨酸激酶抑制剂PD153035在体外抑制恶性胸膜间皮瘤细胞中促转移表型的表达。
J Thorac Cardiovasc Surg. 2005 May;129(5):1010-7. doi: 10.1016/j.jtcvs.2004.10.040.
5
Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy.胸膜内免疫疗法：胸膜恶性肿瘤新兴治疗策略的最新进展
Clin Respir J. 2019 May;13(5):272-279. doi: 10.1111/crj.13010. Epub 2019 Mar 24.
6
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.恶性胸膜间皮瘤：治疗选择的最新进展，重点关注新型疗法。
Clin Chest Med. 2013 Mar;34(1):99-111. doi: 10.1016/j.ccm.2012.12.005. Epub 2013 Jan 17.
7
[Molecular heterogeneity of malignant pleural mesotheliomas].[恶性胸膜间皮瘤的分子异质性]
Bull Cancer. 2018 Jan;105(1):35-45. doi: 10.1016/j.bulcan.2017.11.007. Epub 2017 Dec 23.
8
A catalogue of treatment and technologies for malignant pleural mesothelioma.恶性胸膜间皮瘤的治疗方法与技术目录
Expert Rev Anticancer Ther. 2016;16(4):455-63. doi: 10.1586/14737140.2016.1162100.
9
Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transfer.免疫功能正常大鼠的胸膜间皮瘤：一种研究腺病毒基因转移的模型
Ann Thorac Surg. 1995 Sep;60(3):593-7; discussion 597-8. doi: 10.1016/0003-4975(95)00507-H.
10
Advances in the biology of malignant pleural mesothelioma.恶性胸膜间皮瘤的生物学进展。
Cancer Treat Rev. 2011 Nov;37(7):543-58. doi: 10.1016/j.ctrv.2011.01.001. Epub 2011 Feb 1.
本文引用的文献
1
CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer.CRISPR/Cas9 和下一代测序在癌症个体化治疗中的应用。
Mol Cancer. 2022 Mar 24;21(1):83. doi: 10.1186/s12943-022-01565-1.
2
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.阿贝西利治疗p16ink4A缺陷型间皮瘤患者（MiST2）：一项单臂、开放标签的2期试验。
Lancet Oncol. 2022 Mar;23(3):374-381. doi: 10.1016/S1470-2045(22)00062-6. Epub 2022 Feb 11.
3
Malignant pleural mesothelioma with an EML4-ALK fusion: Expect the unexpected!具有 EML4-ALK 融合的恶性胸膜间皮瘤：意料之外，情理之中！
Pathol Res Pract. 2022 Mar;231:153772. doi: 10.1016/j.prp.2022.153772. Epub 2022 Jan 19.
4
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment.恶性胸膜间皮瘤：DNA修复基因中的种系变异可能指导个性化治疗。
Eur J Cancer. 2022 Mar;163:44-54. doi: 10.1016/j.ejca.2021.12.023. Epub 2022 Jan 13.
5
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.恶性胸膜间皮瘤：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Feb;33(2):129-142. doi: 10.1016/j.annonc.2021.11.005. Epub 2021 Nov 30.
6
Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.多部位肿瘤取样突出了恶性胸膜间皮瘤的肿瘤内分子异质性。
Genome Med. 2021 Jul 14;13(1):113. doi: 10.1186/s13073-021-00931-w.
7
Use of preclinical models for malignant pleural mesothelioma.恶性胸膜间皮瘤的临床前模型应用。
Thorax. 2021 Nov;76(11):1154-1162. doi: 10.1136/thoraxjnl-2020-216602. Epub 2021 Mar 10.
8
A Novel Malignant Peritoneal Mesothelioma with STRN Exon 2 and ALK Exon 20: A Case Report and Literature Review.一例伴有STRN外显子2和ALK外显子20改变的新型恶性腹膜间皮瘤：病例报告及文献复习
Oncologist. 2021 May;26(5):356-361. doi: 10.1002/onco.13714. Epub 2021 Feb 22.
9
Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma.恶性胸膜间皮瘤中甲基硫代腺苷磷酸化酶（MTAP）蛋白表达与 MTAP 和 CDKN2A 拷贝数的相关性。
Histopathology. 2021 Jun;78(7):1032-1042. doi: 10.1111/his.14324. Epub 2021 Apr 14.
10
Mesothelial cells regulate immune responses in health and disease: role for immunotherapy in malignant mesothelioma.间皮细胞在健康和疾病中调节免疫反应：免疫疗法在恶性间皮瘤中的作用。
Curr Opin Immunol. 2020 Jun;64:88-109. doi: 10.1016/j.coi.2020.04.005. Epub 2020 May 30.
Zotero 插件